Immunohistochemically, tumor cells are usually positive for CD3, CD8, CD56, TIA-1, granzyme B, and perforin, and negative for CD4 and CD5, consistent with the findings in our patient [5,6,8,13,14]. Here, PRF1 is linked to neoplasm.